Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA studyShannon M. Vandriel, Catherine Larson‐Nath, Lorenzo D’Antiga et al.|Hepatology|2022Cited by 91
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALABettina E. Hansen, Shannon M. Vandriel, Pamela Vig et al.|Hepatology|2023Cited by 33
Population pharmacokinetics of mycophenolic acid in children and young people undergoing blood or marrow and solid organ transplantationLihua Zeng, Andrew J. McLachlan, E. Blair et al.|British Journal of Clinical Pharmacology|2010Cited by 29
Clinical features and natural history of 1154 Alagille syndrome patients: results from the international multicenter GALA study groupShannon M. Vandriel, Pınar Bulut, Liting Li et al.|Journal of Hepatology|2020Cited by 10
Phenotypic Divergence of <i>JAG1</i> ‐ and <i>NOTCH2</i> ‐Associated Alagille Syndrome & Disease‐Specific <i>NOTCH2</i> Variant Classification GuidelinesShannon M. Vandriel, Chatmanee Lertudomphonwanit, Liting Li et al.|Liver International|2025Cited by 4